NanoViricides Inc. (NNVC)

[Doctor_Hari_Seldon]

The bottom line is this:

Indications are that toxicity is extremely low or essentially none existant and that both that and effectiveness is likely translateable to all other viral applications, then coupled with;

'Extremely high efficacy has been demonstrated for FluCide in highly lethal animal studies against both group I Influenza A (H1N1) and group II influenza A (H3N2) viruses, indicating that this drug is indeed broad-spectrum and should work against most if not all strains of Influenza. The Company has previously reported that injectable FluCide resulted in full 21 day survival of 100% of animals in a highly lethal influenza virus challenge study. To compare, 100% of Tamiflu(R)-treated animals died in 8 days and 100% of untreated animals died in 5 days, in this study. The injectable FluCide treatment resulted in a greater than 1,000-fold reduction in lung viral load, as compared to only a less than 2-fold reduction for Tamiflu-treated animals at the same time point in this study.'

You just cannot beat that in the field of medicine.

THANK YOU NNVC for your work to help save lives!

Wishing all the best of good buys!

HS